InvestorsHub Logo
Followers 0
Posts 107
Boards Moderated 0
Alias Born 03/07/2017

Re: helpx post# 666

Friday, 06/16/2017 11:22:50 AM

Friday, June 16, 2017 11:22:50 AM

Post# of 1317
Have you read the latest 10Q ?
at http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12128673
Have you read the website at
http://hadvinc.com
Have you researched the Management?

There has been ZERO pump on this.

The Management is mainly PHD's with pharmaceutical backgrounds.


The CEO, for example, is former Pfizer Inc. NYSE: PFE y are slowly building a REAL company with real products and eventually real revenues. Rome wasn't built in a day but the upside is here.

Cebidiofen

Cebidiofen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464442) for a pharmaceutical food made from Ibuprofen and a botanical extract blends containing cannabidiol and kava tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).

Polyoxyfen

Polyoxyfen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464423) for a pharmaceutical food made from Ibuprofen and a botanical extract blends containing mitragyna speciose tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).Current Research Pipeline.